Evaluation of small molecule PD-1/PD-L1 inhibitors in a T cell reporter system
{{output}}
Antibodies that block PD-1 signaling, known as immune checkpoint inhibitors (ICIs), have revolutionized cancer treatment. Small molecule inhibitors of the PD-1/PD-L1 interaction could serve as promising alternatives to antibody-based ICIs, offering advantages ... ...
